Kishan D. Patel, Chhaganbhai N. Patel, Grishma M. Patel
Kishan D. Patel1*, Chhaganbhai N. Patel2, Grishma M. Patel3
1Shree S. K. Patel College of Pharmaceutical Education & Research, Gujarat, India.
2Shri Sarvajanic Pharmacy College, Gujarat, India.
3K. B. Institute of Pharmaceutical Education & Research, Gujarat, India.
Volume - 5,
Issue - 1,
Year - 2015
A new series of 4-((2,4-dioxathiazolidin-5-ylidine)methyl)substituted benzene sulphonamide was prepared. The purity of the new compounds was checked by TLC and elucidation of their structures was confirmed by IR, 1H-NMR and mass spectroscopy. All the target compounds were evaluated for their in vivo antidiabetic activity on male Wistar rats by Oral Glucose Tolerance Test (OGTT) method using pioglitazone as standard. Amongst all, compound K17 and K18 exhibited more prominent antidiabetic activity. The results were statistically verified for its significance.
Cite this article:
Kishan D. Patel, Chhaganbhai N. Patel, Grishma M. Patel. Synthesis and Antidiabetic Activity of Novel 4-((2,4-Dioxothiazolidin-5-ylidene)methyl)Substituted Benzene Sulphonamide. Asian J. Res. Pharm. Sci. 5(1): Jan.-March 2015; Page 1-7. doi: 10.5958/2231-5659.2015.00001.6